CORCEPT THERAPEUTICS INC — Director's Dealing 2021

Apr 17, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CORCEPT THERAPEUTICS INC (CORT)
CIK: 0001088856
Period of Report: 2021-04-14

Reporting Person: WILSON JAMES N (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-04-14	Common Stock	M	200000	$4.42	Acquired	200000	Direct
2021-04-14	Common Stock	F	90517	$22.95	Disposed	109483	Direct
2021-04-14	Common Stock	J	109483	$0.00	Disposed	0	Direct
2021-04-14	Common Stock	J	109483	$0.00	Acquired	1174845	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-04-14	Stock Option (Right to Buy)	$4.42	M	200000	Disposed	2021-05-19	Common Stock (200000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	901067	Indirect

Footnotes

F1: These shares were withheld so the Reporting Person could satisfy the exercise price and tax liability arising from a net (cashless) exercise of stock options that occurred on April 14, 2021. The options subject to the net exercise were to expire on May 19, 2021.

F2: Transfer of shares without consideration to the James N. Wilson and Pamela D. Wilson Trust.

F3: Reporting Person has voting power over the shares held by the James N. Wilson and Pamela D. Wilson Trust and James and Pamela Wilson Family Partners pursuant to voting agreements and disclaims beneficial ownership of all of such shares, except to the extent of his pecuniary interest therein.

F4: Fully exercisable.